News

Needle-free technology, originally developed at the AIBN, has been used to administer a COVID-19 vaccine candidate to successfully protect mice, demonstrating the potential of non-invasive delivery.

A pilot facility at AIBN could be producing mRNA vaccines and cancer therapies for research and development within months after receiving backing from the Australian Government.

Faster-charging and more sustainable batteries with a life up to three times greater than lithium ion are being built with technology developed at AIBN.

University of Queensland scientists have published the clinical trial data confirming their molecular clamp-stabilised vaccine technology was safe and potentially effective.

On International Womens’ Day, we asked AIBN’s Dr Nasim Amiralian what advice she would give to her 16-year-old self, if she could mentor a younger Nasim.

Greenhouse gas waste from factories could be turned into environmentally-friendly chemicals and fuels under an international project seeking to better understand the gene function of bacteria.

AIBN researchers have developed a diagnostic device, called an Immuno-storm chip, that could identify which cancer and COVID-19 patients are at risk of a potentially lethal ‘cytokine storm’.

Astronauts aboard the International Space Station (ISS) are conducting experiments with an antimicrobial surface developed at AIBN.

AIBN’s Professor Yusuke Yamauchi has been named as a Research Project Director by the Exploratory Research for Advanced Technology (ERATO) funding program, an initiative of the Japan Science and Technology Agency.

Professor Lianzhou Wang and Professor Yusuke Yamauchi have been named among the world’s most influential minds for 2020’s Highly Cited Research list.

A materials scientist from AIBN has been recognised by a prestigious national body for using his scientific and engineering expertise to help solve global challenges.

A colourful landscape with a large rock in the centre or intestinal microfold monolayer cells?
The 2020 AIBN Science Image Contest has highlighted the role imagination and creativity play in scientific research.

Sugarcane waste could be a key ingredient in tackling plastic pollution, with an AIBN researcher receiving funding to turn the green waste into sustainable packaging.

AIBN researcher Associate Professor Jessica Mar has received a 2020 Georgina Sweet Award for Women in Quantitative Biomedical Science. The award was given to Assoc Professor Mar for both Excellence in Research and Excellence in Inclusivity.

A startup company developing technology based on University of Queensland (UQ) research has announced it will partner with the US Government to test its needle-free vaccine delivery technology.

AIBN's Professor Kristofer Thurecht and IMB's Professor Robert Parton and are Eureka Prize finalists for their project using VR to solve the problem of visualising complex data.

A healthy gut might be impacting the longevity of people living with Motor Neurone Disease (MND), according to new research from The University of Queensland.

A call to arms has gone out to Queenslanders aged 56 and over to help advance The University of Queensland’s COVID-19 vaccine project.

Pre-clinical testing of The University of Queensland’s COVID-19 vaccine, developed in AIBN labs has produced positive indications about its potential effectiveness and manufacturability.

Most diagnostic methods use costly materials and are time-consuming and expensive to run, but PhD candidate Mostafa Masud and research supervisors Professor Yusuke Yamauchi and Dr MD Shahriar Hossain have developed a cheaper, faster and ultrasensitive biosensor for point-of-care testing.